The activities of Src-family non-receptor tyrosine kinases are regulated by structural changes that alter the orientation of key residues within the catalytic domain. In this study, we investigate the eects of activation loop mutations on regulation of the lymphocyte-speci®c kinase Lck (p56 lck ). Substitution of 5 ± 7 residues amino terminal to the conserved activation loop tyrosine (Y 394 ) increases kinase activity and oncogenic potential regardless of regulatory C-terminal tail phosphorylation levels (Y 505 ), while most mutations in the 13 residues carboxyl to Y 394 decrease kinase activity. Phosphorylation of the Cterminal regulatory tail is carried out by the cytosolic tyrosine kinase Csk and we ®nd that mutations upstream or downstream of Y394 or mutation of Y 394 do not aect the level of Y 505 phosphorylation. In addition, we report that mutations on either side of Y 394 aect substrate speci®city in vivo. We conclude that the high degree of conservation across the entire activation loop of Srcfamily kinases is critical for normal regulation of kinase activity and oncogenicity as well as substrate selection.
Introduction
The activities of Src-family non-receptor tyrosine kinases [SF-NRTKs] are upregulated following phosphorylation of a conserved tyrosine residue (Abraham and Veillette, 1990; Cartwright et al., 1987; Kmiecik and Shalloway, 1987; Marth et al., 1988; PiwnicaWorms et al., 1987) within the activation loop subdomain (Johnson et al., 1996) . Phosphorylation in p60 src occurs primarily through an intermolecular mechanism involving another molecule of Src or a dierent tyrosine kinase (Cooper and MacAuley, 1988; Osusky et al., 1995) . Sequence in this region is highly conserved among SF-NRTKs but diverges between kinase subfamilies ( Figure 1a ) and previous mutational studies focused primarily on the tyrosine residue itself. A Tyr to Phe substitution does not destroy kinase activity of p60 src in vitro, however, removal in SFNRTKs decreases both kinase activity in vivo and the ability to transform cells (Abraham and Veillette, 1990; Kmiecik and Shalloway, 1987; Piwnica-Worms et al., 1987) .
Recent crystal structure analyses of receptor (Hubbard, 1997; Hubbard et al., 1994; Mohammadi et al., 1996) and SF-NRTKs (Schindler et al., 1999; Sicheri et al., 1997; Xu et al., 1997 Xu et al., , 1999 Yamaguchi and Hendrickson, 1996) complement earlier mutagenesis studies that revealed the importance of the activation loop tyrosine for activity. The catalytic domain consists of two globular lobes and enzymatic activity is regulated through conformational changes that aect positioning of residues critical for ATP binding, gphosphate transfer, and substrate interaction. Structures of SF-NRTKs suggest that stabilization of the regulatory changes hinge on the phosphorylation state of the activation loop tyrosine residue. Negative regulation results from misalignment of the catalytic residues in the N-terminal lobe of the kinase where in the unphosphorylated Src and Hck enzymes, the catalytic lysine residue (K 295 in Src) is displaced from the correct orientation necessary for electrophillic attack on ATP and g-phosphate transfer. The structures appear to be stabilized by steric interactions of residues at the beginning of the activation loop with the N-terminal lobe of the kinase domain. Inactive conformations of the kinases also appear to block access to the substrate binding site. Phosphorylation of the activation loop tyrosine induces and stabilizes conformational changes that shift the N-terminal lobe residues into an active conformation and allows access to the substrate binding site.
Although a number of mutational studies have shown the importance of the activation loop tyrosine, relatively few studies have proven the regulatory contributions of the remaining activation loop residues. The structural analysis studies of kinases in complex with inhibitor peptides suggest that this region may also be important for substrate selection (Hubbard, 1997; Madhusudan et al., 1994; Zheng et al., 1993) . Several naturally occurring activation loop mutations in the Ret receptor (Hofstra et al., 1994) and Btk (Sideras and Smith, 1995) tyrosine kinases aect activation while mutation at a dierent residue in the Kit receptor alters substrate selection (Piao et al., 1996) . Substitution of the loop in Lck with a homologous domain from the Ser/Thr kinase c-raf decreased autophosphorylation and altered substrate speci®city (Carrera et al., 1995) .
In this study, we have examined the contributions of activation loop residues in regulating the activity of Lck in vivo (Figure 1b) . We have made single and triple amino acid substitutions throughout the activation loop (Ala 381 ± Ala 408 ) with speci®c amino acids chosen to mimic those found in other kinases to retain activity or to add charged residues to maximize changes in substrate speci®city (Figure 1c ). Mutants were then expressed in bacteria or mammalian cells and eects on kinase regulation were examined. With exception to the activating tyrosine residue itself, no other amino acids within the loop have been reported to be essential for the binding or catalysis of ATP, yet we ®nd that many of the substitutions have signi®cant eects on kinase activity and cellular transformation potential. We propose that the high degree of activation loop sequence conservation in SF-NRTKs is important both for substrate speci®city and regulation of kinase activity.
Results
We have made a series of amino acid mutations throughout the activation loop of Lck to assess the contributions of the region on regulation or kinase activity and substrate selection (Figure 1 ). Single amino acid substitutions were chosen either to resemble residues found in other kinases or to add charged residues to maximize the potential eects on substrate selection. In the case of changes immediately downstream of the activating tyrosine Y 394 , triplet substitutions were made to maximize disruption of potential SH2 interactions at this site. Mutant enzymes isolated from bacterial and mammalian expression systems were assayed using both the wildtype (Wt) and activating (Y 505 F) backgrounds. Since we were concerned about the eects of these mutations on the oncogenic potential of Lck as well its biochemical behavior, all mammalian cell measurements were made in murine ®broblasts rather than in transformed T cell lines.
Mutations N-terminal to Y 394 can activate the kinase Crystal structure analyses of receptor tyrosine kinases and SF-NRTKs suggest that amino acids near the beginning of the activation loop are involved with the regulation of kinase activity (Hubbard et al., 1994; Mohammadi et al., 1996; Schindler et al., 1999; Sicheri et al., 1997; Xu et al., 1997 Xu et al., , 1999 Yamaguchi and Hendrickson, 1996) . To investigate the contributions of this region to kinase regulation, we have analysed the eects of mutations at two sites in the activation loop (Leu 388 and Glu 390 ) on the activity of Wt Lck or the activated variant, Y 505 F, expressed in both bacteria and mammalian cells. Because bacteria do not express endogenous tyrosine kinases, no PTyr proteins are observed in the bacterial lysates in the absence of exogenous Lck expression (data not shown). When Lck is expressed in the bacteria, both Wt and Y 505 F mutant proteins exhibit similar kinase activities as judged by autokinase activity and by overall levels of PTyr on bacterial substrates because the bacteria lack expression of the down regulatory kinase Csk (Figure 2a ). Mutations at Leu 388 to Asn (L 388 N) and at Glu 390 to Thr (E 390 T) have little aect on activity, both in the Wt and Y 505 F backgrounds. Mutation of each site to bulkier (Met; E 390 M) or charged residues (Asp; L 388 D) measurably reduces kinase activity towards bacterial proteins (as does the double mutant L 388 D/E 390 M). The same experiment can also be used to analyse the mutants for dierences in substrate speci®city by comparing the proteins tyrosine phosphorylated in the total lysates. An activation loop mutation was determined to aect substrate speci®city if the PTyr pattern for the mutant diered from that of the Wt and Y505F lysates, either by adding new proteins to the phosphorylation pattern or by decreasing tyrosine phosphorylation on a subset of the proteins. Despite their apparent distance from the reported substrate binding pocket, mutations at both Leu 388 and Glu 390 have subtle eects on speci®city, decreasing the PTyr content on some proteins while not aecting others, depending on the amino acid substitution. Substitution of a charged residue (Asp) at Leu 388 has more aect on substrate selection and overall activity than substitution to the neutral amino acid (Asn). Similar results were observed for the mutations at Glu 390 where substitution to Met has more aect on activity than does the substitution to Thr. Notably, the only previously reported mutations in this portion of the activation loop of any tyrosine kinase were spontaneous activating mutations in the Kit receptor at Asp 816 , analogous to position Leu 388 in Lck. In these mutants, the Asp residue was substituted with either Val or Tyr, which also led to altered substrate speci®city (Piao et al., 1996) .
To examine the eects of these substitutions on kinase activity in the presence of the downregulatory (Xu et al., 1997) , Lck (Yamaguchi and Hendrickson, 1996) , Hck (Sicheri et al., 1997) , FGFR (Mohammadi et al., 1996) , and IRK (Hubbard et al., 1994) as referenced in previous crystal structure studies kinase Csk, the mutant Lck enzymes were expressed in ®broblasts. Previous studies have reported that Wt Lck is tyrosine phosphorylated only at Y 505 in ®broblasts, which serves to downregulate the enzyme via an intramolecular SH2 interaction (Abraham and Veillette, 1990; Amrein and Sefton, 1988; Gervais et al., 1993; Marth et al., 1988; Weil and Veillette, 1994) . In contrast to the activity observed with expression in bacteria, Wt Lck is inactive towards proteins in mammalian cells while Y 505 F Lck is constitutively active and transforming (Figure 2b , and corresponding Y 505 F double mutants were subcloned into the prokaryotic expression vector pGEX-2T. Uninduced bacterial total lysates normalized for Lck levels were analysed for dierences in PTyr content by Western blotting using anti-PTyr (4G10). Blots were stripped and then re-probed using anti-Lck polyclonal sera. The position of the gst-Lck protein is indicated. Dierences in substrate phosphorylation patterns due to Lck proteolysis have been ruled out by using both N-and C-terminal Lck peptide anti-sera to identify breakdown products. The ability of a given Lck mutant to direct phosphorylation of cellular proteins correlates well with the degree of transformed morphology in the ®broblast monolayers (Figure 2c) . Thus, the L 388 N cells exhibited the greatest increase in kinase activity in the Wt background (Figure 2b) , and, not surprisingly, the L 388 N cells appeared to be partially transformed, having a more rounded phenotype (Figure 2c) . Similarly, most of the mutants show slightly decreased kinase activity in a Y 505 F background and also display a level of morphological transformation which is slightly down from the Y 505 F single mutant, with the L 388 D/E 390 M/Y 505 F triple mutant having the least transformed morphology.
Mutations immediately downstream of Y 394 decrease kinase activity but do not affect Y 505 phosphorylation
Several studies have suggested that the highly conserved sequence within the activation loop of SFNRTKs is important for binding to the downregulatory kinase Csk via its SH2 domain (Bougeret et al., 1996; Songyang et al., 1994) . Current models based on crystal structure analyses of SH2 domains show that the activating PTyr and three amino acids immediately C-terminal to the phosphorylated tyrosine residue are most important for determining SH2 binding speci®city (Eck et al., 1993; Waksman et al., 1993) . Therefore, we constructed mutants in the three amino acids following Y 394 and analysed the mutant proteins ®rst for eects on autophosphorylation and kinase activity and then subsequently for eects on downregulation by Csk. We made three mutations, one which changed the wild type sequence Tyr-Thr-Ala-Arg (YTAR) to Tyr-CysPro-Lys (YCPK), the sequence found in the Drosophila Src64 homolog, and two others, Tyr-Gly-Gln-Gln (YGQQ) and Tyr-Asn-Gln-Gln (YNQQ), which were chosen to minimize the chance of binding either Csk or other SH2 containing proteins.
Autophosphorylation of Lck occurs primarily via an intermolecular trans-phosphorylation mechanism in vivo when expressed in bacterial systems (Jullien et al., 1994 (Figure 3c ). The dierences in Lck activity in vivo do not result from a loss of intrinsic kinase activity as all the mutants are kinase active using enolase as a substrate in vitro (Figure 3d) Veillette, 1990; Amrein and Sefton, 1988; Gervais et al., 1993; Weil and Veillette, 1994) . When Y 505 has been either mutated or deleted, then Y 394 is the only site of tyrosine phosphorylation (Abraham and Veillette, 1990; Amrein and Sefton, 1988; Gervais et al., 1993; Weil and Veillette, 1994) . To eliminate the possibility of any background autophosphorylation at Y 394 , the PTyr were re-examined using constructs containing an additional Lys 273 to Arg mutation (K 273 R), which has been shown to inactivate the kinase domain by disrupting the phosphate-transfer reaction. As shown in Figure 4b, were inactive as measured by the ability to phosphorylate proteins in vivo (data not shown). The inactivity of several mutants was further veri®ed by comparing the ability of each mutant to transphosphorylate itself using in vitro kinase assays. The K 405 D, K 405 G, T 407 D, and T 407 R mutants all exhibited autokinase activities that were 500 ± 1200 times less than that of Wt Lck (data not shown). However, the Lck mutants in this region that retained activity showed signi®cant changes in substrate phosphorylation patterns when expressed in bacteria (Figure 5a ). The changes result mainly from a loss in The mutant proteins were then expressed in ®broblasts and their activities were compared to that of Wt and Y 505 F Lck (Figure 5b) . The Gly 399 , Lys 401 , and Thr 407 single mutants have PTyr levels similar to that of Wt Lck, indicating that they are regulated by Y 505 phosphorylation in a manner similar to wild type. When these mutants were expressed in a Y 505 F background, the order of activity levels mimicked that observed in bacteria with the K 401 S mutant being most similar to Y 505 F followed by the T 407 A and G 399 A mutants. In most cases, changes in overall levels of tyrosine phosphorylation in cells expressing the mutant proteins correlate well with the changes in cellular transformation in the ®broblast monolayer (Figure 5c ). However, the similarity in PTyr blotting patterns between Y 505 F and G 399 A/Y 505 F stands in contrast to the relatively large dierence in the morphologies of cells expressing these proteins. This suggests that the G 399 A/Y 505 F mutant has lost the ability to phosphorylate a key substrate necessary for changes in transformation.
Discussion
The activation loop in tyrosine kinases is believed to be important for regulation of kinase activity via conformation stabilization and determination of substrate selection. However, no systematic mutational analysis has been reported and structural analyses have been dicult since the region is not well ordered in most crystals. In this study, we analysed the eects of a series of amino acid mutations across the activation loop in Lck on the regulation of kinase activity and substrate selection. Our mutagenesis results veri®ed a number of predictions from crystallographic studies for the role of the conserved activation loop in enzyme regulation.
From structural analyses, regulation of kinase activity in SF-NRTKs occurs either from stabilization of the active conformation through phosphorylation of the activation loop Tyr or stabilization of the inactive conformation by SH3/linker and SH2/C-terminal Tyr interactions. Our results indicate that, in addition to these mechanisms, SF-NRTKs exist in a basal inactive state that is stabilized through intramolecular interactions involving the amino terminal region of the activation loop and most likely with the amino terminal lobe of the catalytic domain. We show that mutations in the conserved amino terminal region of the activation loop (L 388 D, L 388 N, and L 388 D/E 390 M) activate Lck in vivo, coincident with increased levels of PTyr on the kinase, but have little eect on substrate speci®city. Mutation of a nearby residue, Ile 389 to Ala, also increased the basal activity of Lck expressed in ®broblasts whereas the mutation Asn 392 to Thr did not (LE Laham, unpublished results). Disruption of this region partially activates Lck by relieving the autoinhibitory mechanism and subsequent phosphorylation of either the activation loop tyrosine (Y 394 ) or the regulatory tail tyrosine (Y 505 ) shifts the kinase into a more strongly active or inactive conformation, respectively. These ®ndings con®rm the hypotheses suggested from recent crystals for Src and Hck that this region stabilizes an inactive conformation of the kinase by displacing helix aC from an enzymatically favorable conformation (Schindler et al., 1999; Sicheri et al., 1997; Xu et al., 1997 Xu et al., , 1999 . Dierences in primary sequence for this region of the activation loop may re¯ect dierences in the level of negative regulation required for dierent classes of tyrosine kinases.
The central region of the activation loop contains the structurally important Y 394 residue which when phosphorylated induces a rearrangement in the loop near Leu 385 -Arg 387 that stabilizes the enzyme's active conformation. Amino acid sequences around the tyrosine residue are highly conserved in all mammalian Src homologs except the myeloid-speci®c member Fgr. Although the sequence in Fgr diverges, it still is eciently downregulated by Csk (Ruzzene et al., 1994) . We ®nd that mutation of Y 394 and the three amino acids immediately downstream (TAR) does not aect C-terminal phosphorylation of Lck in vivo. However, the mutations do decrease kinases activity and revert the morphological transformed phenotype of Y 505 F mutants with the extent of reversion correlating with the levels of decreased Y 394 phosphorylation. Although some of these mutants are less active than their Wt counterparts, dierences in substrate speci®city are more easily recognized than with the mutants near the beginning of the activation loop. As all of our mutants are active towards exogenous substrate when immunoprecipitated but are not active in bacteria or mammalian cells, we believe that the three amino acids Substitution of amino acids near the carboxyl end of the activation loop has the most signi®cant eect on kinase activity and substrate speci®city. Most mutations in this region decrease or abolish kinase activity when measured using in vivo and in vitro assays. The lack of activity is particularly surprising since most of the residues in the loop do not appear to be making signi®cant contributions for stabilizing the kinase into active or inactive conformations with exceptions of the Y 394 and T 407 residues (Schindler et al., 1999; Sicheri et al., 1997; Xu et al., 1997 Xu et al., , 1999 Yamaguchi and Hendrickson, 1996) . In the inactive kinase, T 407 interacts with R 387 near the beginning of the activation loop and helps to stabilize the displacement of helix aC. Therefore, mutations at this site might be expected to activate the kinase by partially relieving the loop's autoinhibitory steric hindrance mechanism, but this was not found to be the case as mutations at T 407 decreased or abolished kinase activity. In addition, in the active kinase, phosphorylated Y 394 interacts with Arg 363 and Arg 387 that induces a shift of the entire activation loop away from the substrate binding pocket. This may explain, in part, the lack of activity for the carboxy terminal end mutants in vivo since they contain lower levels of Y 394 phosphorylation. However, the four mutants in this region analysed in vitro (K 405 D, K 405 G, T 407 D, and T 407 R) were also inactive upon immunoprecipitation. Despite the lack of recognition in earlier SF-NRTK structural studies, our results suggest that the amino acids near the carboxy terminal end of the activation loop are essential for catalytic function, possibly by stabilization of the active conformation Y 394 positioning or proper placement of peptide substrates.
For the activation loop mutants near its carboxyl end that retained kinase activity, dierences in substrate selection are clearly evident. Crystal structure analysis of the activated insulin receptor-peptide substrate complex indicated that this region of the activation loop (L 1171 -M 1176 in IRK; F 402 -T 407 in Lck) forms part of two adjacent hydrophobic pockets that bind to the Y+1 and Y+3 residues on the substrate (Hubbard, 1997) . Substitution at T 407 in Lck had the most signi®cant eects on substrate selection when expressed in both bacterial and mammalian systems. Notably, the mutants at T 407 seem to be unable to phosphorylate available substrates rather than gaining the ability to phosphorylate new substrates. This is consistent with the idea that the loop is playing a key role in substrate interactions but that other nearby regions are also important for determining substrate selection. Interestingly, substitution of an adjacent residue, W 406 Y, destroyed Lck's ability to phosphorylate exogenous substrates when expressed in bacteria yet the mutant retained ability to phosphorylate itself (Mukhopadhyay, unpublished work). Several additional mutations further away from the T 407 residue, G 399 A and K 401 S, have altered substrate speci®city that is more pronounced with expression in bacteria than mammalian cells. These mutants also display dierences in ®broblast monolayer morphologies from that of Y 505 F to suggest the subtle loss of key substrate phosphorylations in mammalian cells. We believe that this region, in coordination with the region near T 407 , may be making speci®city contacts with substrate residues, although we cannot rule out that the changes are indirect due to a local disruption of activation loop structure.
Surprisingly, the conservative substitutions at F 402 in Lck (analogous to the insulin receptor residue hypothesized to interact with the substrate Y+1 residue) destroyed activity. The inactivity of the F 402 , P 403 , and K 405 mutants suggests that the high degree of sequence conservation in this region is essential to retain enzyme activity and probably not important for determining minor dierences in substrate speci®city. Analysis of the active insulin receptor structure suggests that conformation of this region is essential for determining speci®city where the conserved Pro (P 403 in Lck) orients the phenolic ring of the substrate Tyr residue. In our mutants, substitution of any residues in the immediate region of the conserved Pro may still allow substrates to interact with the kinase but inactivate the enzyme due to misalignment of the proline relative to Y 394 .
Taken as a whole our results point to the high level of importance of virtually every residue in the activation loop. This highly conserved element not only helps to hold the basal enzyme activity to a minimum but also regulates the activity and substrate speci®city of the activated enzyme. While none of the mutations that we made at the C-terminus of the loop which changed substrate speci®city retained full oncogenic potential, it is quite possible that mutations can be made in this region which will dramatically change the oncogenic nature of Lck by altering substrate speci®city while retaining catalytic activity.
Materials and methods

Construction of bacterial and retroviral vectors
The synthetic human Lck cDNA (synk), cloned into prokaryotic expression vector pGEX-2T (Pharmacia Biotech Inc., Piscataway, NJ, USA), contains silent mutations that insert unique restriction enzyme sites every 20 ± 40 nucleotides and was used for all Lck plasmid constructions (Carrera et al., 1995 ; AC Carrera and TM Roberts, unpublished results).
Restriction and modifying enzymes were purchased from N.E. BioLabs (Beverly, MA, USA) except where noted. Prior to construction of mutations within the activation loop of Lck, the 3' 800 bp HindIII ± EcoRI fragment of synk was cloned into the vector pGEM3zf + (Promega, Madison, WI, USA). A new silent mutation was generated by substituting a BssHII ± S®I double-stranded oligo (5' cg cgc gag ggc gcc aag ttt ccc att aag tgg acg gcc cca g 3') into the backbone that created a NarI restriction enzyme site at nucleotides 1198 ± 1203 to facilitate mutagenesis of the region.
To create the speci®c activation loop mutations at, or immediately C-terminal to Y 394 , double-stranded NheI ± NarI oligos (Y 394 F:5'cta gca cgc ctc att gag gac aac gag ttc aca gcg cgc gag gg3'; YCPK: 5'cta gca cgc ctc att gag gac aac gag tac tgc cct aag gag gg3'; YGQQ: 5'cta gca cgc ctc att gag gac aac gag tac gga cag cag gag gg3'; YNQQ: 5'cta gca cgc ctc att gag gac aac gag tac aac cag cag gag gg3') were subcloned into the NheI ± NarI digested synk-pGEM3zf + backbone. To generate the activation loop mutations N-terminal to Y 394 , doublestranded NheI ± BssHII oligos (L 388 D: 5'cta gca cgc gat att gag gac aac gag tac aca g3'; L 388 N: 5'cta gca cgc aat att gag gac aac gag tac aca g3'; E 390 M: 5'cta gca cgc ctc att atg gac aac gag tac aca g3'; E 390 T: 5'cta gca cgc ctc att acc gac aac gag tac aca g3'; L 388 D/E 390 M: 5'cta gca cgc gat att atg gac aac gag tac aca g3') were subcloned into the NheI ± BssHII digested synk-pGEM3zf + backbone. To generate the point mutations at K 405 , double-stranded NarI ± S®I oligos (K405D: 5'c gcc aag ttt ccc att gac tgg acg gcc cca g3'; K405F: 5'c gcc aag ttt ccc att ttc tgg acg gcc cca g3'; K405G: 5'c gcc aag ttt ccc att ggc tgg acg gcc cca g3') were subcloned into the NarI ± S®I digested synk-pGEM3zf + backbone. Fulllength Lck cDNA was re-generated by ligation of the NarI + Wt and mutated 800 bp HindIII ± EcoRI cDNA fragments back with the synk-pGEX-2T HindIII ± EcoRI plasmid backbone. To generate the remaining amino acid mutations downstream of Y 394 , double-stranded HincII ± S®I fragments were PCR generated, digested with HincII and S®I, and then subcloned into the HincII and S®I digested synk-pGEX2T backbone. The upstream PCR oligo at the HincII site was 5'tgc tct aga cat ggc agc cca aat tgc3' while the downstream PCR oligos containing the point mutations are summarized as follows: G 399 A: 5'cgg ggt acc gta gtt aat ggc ctc tgg ggc cgt cca ctt aat ggg aaa ctt ggc ggc ctc3'; K 401 S: 5'cgg ggt acc gta gtt aat ggc ctc tgg ggc cgt cca ctt aat ggg aaa gct ggc tcc3'; F 402 I: 5'cgg ggt acc gta gtt aat ggc ctc tgg ggc cgt cca ctt aat ggg gat ctt gcc3'; F 402 A: 5'cgg ggt acc gta gtt aat ggc ctc tgg ggc cgt cca ctt aat ggg tgc ctt ggc3'; P 403 S: 5'cgg ggt acc gta gtt aat ggc ctc tgg ggc cgt cca ctt aat tga aaa ctt3'; P 403 T: 5'cgg ggt acc gta gtt aat ggc ctc tgg ggc cgt cca ctt aat tgt aaa ctt3'; W 406 Y: 5'cgg ggt acc gta gtt aat ggc ctc tgg ggc cgt gta ctt aat 3'; T 407 A: 5'cgg ggt acc gta gtt aat ggc ctc tgg ggc tgc cca ctt aat3'; T 407 D:5'cgg ggt acc gta gtt aat ggc ctc tgg ggc gtc cca ctt aat3'; T 407 M: 5'cgg ggt acc gta gtt ggc ctc tgg ggc cat cca ctt aat3'; T 407 R: 5'cgg ggt acc gta gtt aat ggc ctc tgg ggc cct cca ctt aat3'; T 407 S: 5'cgg ggt acc gta gtt aat aac ctc tgg ggc tga cca ctt aat3'. To generate the activating Cterminal mutations at Y 505 in Lck, a 3' 287 bp KpnI ± EcoRI fragment of synk/Y 505 F was substituted for the fragment in the wildtype (Wt) and the activation loop mutant constructs. To verify that all clones obtained the correct mutations, one strand of the cDNA fragments was sequenced using the chain termination method with Sequenase 2.0 (Amersham, Cleveland, OH, USA). All oligos were generated either by the DFCI core facility or purchased from Integrated DNA Technologies (Coralville, IA, USA). For construction of Y 505 F, YCPK, YGQQ, YNQQ and Y 394 F mutants in mammalian expression vectors, Wt Lck and mutant cDNA's were subcloned into pLNCX (Clontech, Palo Alto, CA, USA). The vector was ®rst modi®ed by adding a BglII restriction enzyme site into the multiple cloning site at the HindIII site. Wt and mutant Lck cDNA fragments were generated by digestion of the pGEX-2T clones with NcoI and EcoRI and the fragments were ligated after blunt-end generation to phosphorylated double-stranded BclI oligos (5'gtg atc ac3') to generate a consensus 5' Kozak sequence. Fragments generated by BclI digestion were subcloned into the newly generated BglII site on pLNCX. To construct the remaining constructs, Lck HindIII ± EcoRI fragments containing the activation loop mutations were subcloned into the Wt Lck/pLNCX or Y 505 F/pLNCX backbones. Kinase inactive Lck constructs were generated by creating K 273 R mutations in the pLNCX expression vectors by substituting the 739 bp BglII ± SalI fragments from K 273 R synk (Carrera et al., 1993) into each of the Wt, Y 394 F, YCPK, YNQQ, and Y 505 F pLNCX mutants.
Cell culture, retroviral infections, and lysate preparations Balb C 3T3 ®broblasts were grown in Dulbecco's modi®ed Eagle's media supplemented with 10% (v/v) calf serum, penicillin, and streptomycin sulfate (Gibco-BRL, Gaithersburg, MD, USA). All cells were grown at 378C in 8% CO 2 . Supernatants from the retroviral packaging cell line pBOSC23 (Pear et al., 1993) were harvested 48 ± 72 h after CaPO 4 -mediated transfection of 10 mg Wt or mutant LckpLNCX plasmids. Balb C cells (0.5610 6 ) were infected with 1/10 ± 1/200th volume of the retroviral supernatants and stable pools were generated from geneticin (G418)-resistant colonies (Gibco-BRL). Stable drug-resistant pools were lysed in ice-cold NP-40 buer (20 mM Tris-HCl pH 8.0, 137 mM NaCl, 10% glycerol, 1% Nonidet P-40) supplemented with protease and phosphatase inhibitors (1 mM phenylmethylsulfonyl¯uoride, 1 mg/ml pepstatin, 1 mg/ml leupeptin, 0.1 TIU/ ml aprotinin, 1 mM NaVO 4 , 25 mM b-glycerol phosphate). Supernatants were collected after centrifugation (14 000 g, 5 min, 48C). Lysates were normalized for total protein content using the BioRad protein assay (BioRad, Richmond, CA, USA) and then analysed for Lck and PTyr content by SDS ± PAGE and immunoblotted as indicated below. To generate Lck bacterial lysates, overnight JM109 bacterial cultures were diluted 1 : 10 in LB containing ampicillin (50 mg/ml) and grown at 378C for four additional hours. Uninduced bacterial pellets were lysed on ice in 1/10th volume (20 mM Tris-HCl pH 8.0, 0.5% Nonidet P-40, 100 mM NaCl, 1 mM EDTA) supplemented with protease and phosphatase inhibitors (1 mM NaVO 4 , 1 mM phenylmethylsulfonyl¯uoride, 25 mM b-glycerol phosphate, 1 mg/ml pepstatin, 1 mg/ml leupeptin, 0.1 TIU/ml aprotinin) followed by bath sonication (three 10 s pulses). All protease and phosphatase inhibitors were obtained from Sigma Chemical Corporation (St. Louis, MO, USA). Supernatants were cleared by centrifugation (14 000 g, 5 min). Lysates were diluted with SDS ± PAGE sample buer and then analysed by standard SDS ± PAGE followed by transfer to Immobilin-P membranes (Millipore, Bedford, MA, USA) and immunoblotted as indicated below.
Immunoblot analysis and immunoprecipitation
Equivalent amounts of total lysate protein obtained from either uninduced bacterial cultures (20 mg) or Balb C 3T3 pools (75 mg) were analysed by SDS ± PAGE and transferred onto Immobilin-P membrane. To determine the levels of Lck protein, blots were probed with either a rabbit polyclonal anti-N-terminal Lck peptide sera (generated against amino
